Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Jehan Mohammad Nazri, Katerina Oikonomopoulou, Elvin D. de Araujo, Dziyana Kraskouskaya, Patrick T. Gunning & Vinod Chandran. (2023) Histone deacetylase inhibitors as a potential new treatment for psoriatic disease and other inflammatory conditions. Critical Reviews in Clinical Laboratory Sciences 60:4, pages 300-320.
Read now
Read now
Piotr Ciechanowicz, Klaudia Dopytalska, Agata Mikucka-Wituszyńska, Monika Dźwigała, Kacper Wiszniewski, Weronika Herniczek, Elżbieta Szymańska & Irena Walecka. (2022) The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapy. Journal of Dermatological Treatment 33:3, pages 1581-1584.
Read now
Read now
Raagav Mohanakrishnan, Secia Beier & Atul Deodhar. (2022) IL-23 inhibition for the treatment of psoriatic arthritis. Expert Opinion on Biological Therapy 22:1, pages 59-65.
Read now
Read now
Valentina Perrone, Serena Losi, Erica Filippi, Diego Sangiorgi & Luca Degli Esposti. (2021) Pattern of drug use in patients with psoriatic arthritis in Italy: study in a real-world setting. Expert Review of Pharmacoeconomics & Outcomes Research 21:4, pages 721-727.
Read now
Read now
Valentina Perrone, Elisa Giacomini, Diego Sangiorgi, Margherita Andretta, Anna Michela Menti, Mariantonietta Naclerio, Daniela Ritrovato & Luca Degli Esposti. (2020) Treatment Pattern Analysis and Health-care Resource Consumption on Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Biological Drugs in a Northern Italian Region. Therapeutics and Clinical Risk Management 16, pages 509-521.
Read now
Read now
Francesco Ursini, Emilio Russo, Roberto De Giorgio, Giovambattista De Sarro & Salvatore D’Angelo. (2018) Current treatment options for psoriatic arthritis: spotlight on abatacept. Therapeutics and Clinical Risk Management 14, pages 1053-1059.
Read now
Read now
Luciana Scalone, Piercarlo Sarzi-Puttini, Luigi Sinigaglia, Carlomaurizio Montecucco, Roberto Giacomelli, Giovanni Lapadula, Ignazio Olivieri, Angela Maria Giardino, Paolo Angelo Cortesi, Lorenzo Giovanni Mantovani & Monica Mecchia. (2018) Patients’, physicians’, nurses’, and pharmacists’ preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases. Patient Preference and Adherence 12, pages 2153-2168.
Read now
Read now
Ombretta Viapiana & Elena Fracassi. (2018) Treatment with secukinumab in multi-comorbid patients with psoriatic arthritis. Journal of Dermatological Treatment 29:sup2, pages 9-11.
Read now
Read now
Articles from other publishers (29)
Nienke J Kleinrensink, Frank T Perton, Juliëtte N Pouw, Nanette L A Vincken, Sarita A Y Hartgring, Mylène P Jansen, Saeed Arbabi, Wouter Foppen, Pim A de Jong, Janneke Tekstra, Emmerik F A Leijten, Julia Spierings, Floris P J G Lafeber, Paco M J Welsing & Marloes W Heijstek. (2022) TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA). BMJ Open 12:10, pages e064338.
Crossref
Crossref
Khalid A. Alnaqbi, Suad Hannawi, Rajaie Namas, Waleed Alshehhi, Humeira Badsha & Jamal Al‐Saleh. (2022) Consensus statements for pharmacological management, monitoring of therapies, and comorbidity management of psoriatic arthritis in the United Arab Emirates. International Journal of Rheumatic Diseases 25:10, pages 1107-1122.
Crossref
Crossref
Philipp Sewerin, Kathrin Borchert, Dominic Meise, Matthias Schneider & Jörg Mahlich. (2022)
Health Resource Utilization and Associated Health Care Costs of Biologic
Disease‐Modifying
Antirheumatic Drugs in German Patients With Psoriatic Arthritis
. Arthritis Care & Research 74:9, pages 1435-1443.
Crossref
Crossref
Simon Hackett, Alexis Ogdie & Laura C. Coates. (2022) Psoriatic arthritis: prospects for the future. Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2210867.
Crossref
Crossref
Chun-Yu Lin, Chung-Yuan Hsu, Hsiao-Ru He, Wei-Yu Chiang, Shang-Hung Lin, Yi-Ling Huang, Yu-Hsia Kuo & Yu-Jih Su. (2022) Gut microbiota differences between psoriatic arthritis and other undifferentiated arthritis: A pilot study. Medicine 101:28, pages e29870.
Crossref
Crossref
I.Yu. Golovach & Ye.D. Yehudina. (2021) Сучасні рекомендації щодо лікування псоріатичного артриту згідно з рекомендаціями Американського коледжу ревматологів і Національної організації з псоріазу 2018 року. PAIN, JOINTS, SPINE 9:1, pages 46-58.
Crossref
Crossref
Akshitha Thatiparthi, Amylee Martin, Jeffrey Liu, Alexander Egeberg & Jashin J. Wu. (2021) Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review. American Journal of Clinical Dermatology 22:4, pages 425-442.
Crossref
Crossref
Signe Holm Nielsen, Samra Sardar, Anne Sofie Siebuhr, Annette Schlemmer, Erik Berg Schmidt, Anne-Christine Bay-Jensen, Morten A. Karsdal, Jeppe Hagstrup Christensen & Salome Kristensen. (2021) Effect of n-3 PUFA on extracellular matrix protein turnover in patients with psoriatic arthritis: a randomized, double-blind, placebo-controlled trial. Rheumatology International 41:6, pages 1065-1077.
Crossref
Crossref
Michael D. Overcash, Christopher Chillura, Sarah P. Fender, Matthew K. Ewald, Aiken McDowell McNair, Michelle Nye & Clint Blankenship. (2021) Psoriatic arthritis: the role of the nonphysician clinician in the diagnosis and treatment of patients with psoriasis. Drugs & Therapy Perspectives 37:4, pages 162-174.
Crossref
Crossref
Alan Menter, Gerald G. Krueger, So Yeon Paek, Dario Kivelevitch, Iannis E. Adamopoulos & Richard G. Langley. (2021) Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities. Dermatology and Therapy 11:2, pages 385-400.
Crossref
Crossref
Tsen-Fang Tsai, Tsu-Yi Hsieh, Ching-Chi Chi, Chung-Tei Chou, Lin-Fen Hsieh, Hsin-Hua Chen, Rosaline Chung-Yee Hui, Chih-Hung Lee, Chin-Hsiu Liu, Hwa-Chang Liu, Kai-Jieh Yeo, Chun-Hsiung Chen, Hung-An Chen, Ying-Chou Chen, Yi-Ju Chen, Hsien-Yi Chiu, Ji-Chen Ho, Yu-Huei Huang, Po-Ju Lai, Woan-Ruoh Lee, Hsien-Tzung Liao, Shang-Hung Lin, Jui-Cheng Tseng, Ting-Shun Wang, Nan-Lin Wu, Deng-Ho Yang, Wen-Chan Tsai & James Cheng-Chung Wei. (2021) Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology. Journal of the Formosan Medical Association 120:3, pages 926-938.
Crossref
Crossref
Philipp Sewerin, Kathrin Borchert, Dominic Meise, Matthias Schneider & Jörg Mahlich. (2021) Real-World Treatment Persistence with Biologic Disease-Modifying Antirheumatic Drugs Among German Patients with Psoriatic Arthritis—A Retrospective Database Study. Rheumatology and Therapy 8:1, pages 483-497.
Crossref
Crossref
Atrin Toussi, Natalia Maverakis, Stephanie T. Le, Soumajyoti Sarkar, Smriti K. Raychaudhuri & Siba P. Raychaudhuri. (2020) Updated therapies for the management of Psoriatic Arthritis. Clinical Immunology 220, pages 108536.
Crossref
Crossref
Giovanni Cagnotto, Michele Compagno, Carlo Alberto Scire & Matteo Bruschettini. (2020) Tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Mingliang Qiu, Zhongbo Xu, Wenjuan Gao, Meizhen Xiong, Xianhua Wen, Weina Zhu, Xu Zhou & Minfeng Yu. (2020) Fourteen small molecule and biological agents for psoriatic arthritis. Medicine 99:31, pages e21447.
Crossref
Crossref
Salvatore D'Angelo, Fabrizio Cantini, Roberta Ramonda, Luca Cantarini, Antonio Carletto, Maria Sole Chimenti, Andrea Delle Sedie, Rosario Foti, Roberto Gerli, Claudia Lomater, Ennio Lubrano, Antonio Marchesoni, Alen Zabotti, Carlo Salvarani, Rossana Scrivo, Raffaele Scarpa, Giuseppina Tramontano, Carlotta Nannini, Mariagrazia Lorenzin, Marta Fabbroni, Federica Martinis, Roberto Perricone, Linda Carli, Elisa Visalli, Guido Rovera, Fabio Massimo Perrotta, Luca Quartuccio, Alessio Altobelli, Luisa Costa, Laura Niccoli, Augusta Ortolan & Francesco Caso. (2019) Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study. Frontiers in Pharmacology 10.
Crossref
Crossref
Shirly Frizinsky, Soad Haj-Yahia, Diti Machnes Maayan, Yulia Lifshitz, Ramit Maoz-Segal, Irean Offengenden, Mona Kidon & Nancy Agmon-Levin. (2019) The innate immune perspective of autoimmune and autoinflammatory conditions. Rheumatology 58:Supplement_6, pages vi1-vi8.
Crossref
Crossref
Hana Ciferská & Jiří Štolfa. (2019) Tofacitinib in treating psoriatic arthritis. Dermatologie pro praxi 13:1, pages 45-48.
Crossref
Crossref
Louis Jacob, Thomas Chevalier & Karel Kostev. (2018) Persistence with biological drugs in patients treated in rheumatology practices in Germany. Rheumatology International 39:3, pages 525-531.
Crossref
Crossref
Amit Khatri, Ben Klünder, Paul M Peloso & Ahmed A Othman. (2019) Exposure–response analyses demonstrate no evidence of interleukin 17A contribution to efficacy of ABT-122 in rheumatoid or psoriatic arthritis. Rheumatology 58:2, pages 352-360.
Crossref
Crossref
Roberto Giacomelli, Antonella Afeltra, Alessia Alunno, Elena Bartoloni-Bocci, Onorina Berardicurti, Michele Bombardieri, Alessandra Bortoluzzi, Roberto Caporali, Francesco Caso, Ricard Cervera, Maria Sole Chimenti, Paola Cipriani, Emmanuel Coloma, Fabrizio Conti, Salvatore D’Angelo, Salvatore De Vita, Salvatore Di Bartolomeo, Oliver Distler, Andrea Doria, Eugen Feist, Benjamin A. Fisher, Maria Gerosa, Michele Gilio, Giuliana Guggino, Vasiliki Liakouli, Domenico Paolo Emanuele Margiotta, Pierluigi Meroni, Gianluca Moroncini, Federico Perosa, Marcella Prete, Roberta Priori, Chiara Rebuffi, Piero Ruscitti, Raffaele Scarpa, Yehuda Shoenfeld, Monica Todoerti, Francesco Ursini, Guido Valesini, Serena Vettori, Claudio Vitali & Athanasios G. Tzioufas. (2019) Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis. Autoimmunity Reviews 18:1, pages 93-106.
Crossref
Crossref
Peter Mohr, Sebastian Haferkamp, Andreas Pinter, Carsten Weishaupt, Margit A. Huber, Gerald Downey, Katarina Öhrling, Carmen Loquai & Karly S. Louie. (2018) Real-World Use of Talimogene Laherparepvec in German Patients with Stage IIIB to IVM1a Melanoma: A Retrospective Chart Review and Physician Survey. Advances in Therapy 36:1, pages 101-117.
Crossref
Crossref
Carolin F. Manthey, Marcial Sebode, Helen Hayward-Koennecke, Andreas Lutterotti & Samuel Huber. 2019. Nijkamp and Parnham's Principles of Immunopharmacology. Nijkamp and Parnham's Principles of Immunopharmacology
751
775
.
Philip Mease, Laura C Coates, Philip S Helliwell, Mykola Stanislavchuk, Anna Rychlewska-Hanczewska, Anna Dudek, Walid Abi-Saab, Chantal Tasset, Luc Meuleners, Pille Harrison, Robin Besuyen, Annegret Van der Aa, Neelufar Mozaffarian, Joy M Greer, Rebecca Kunder, Filip Van den Bosch & Dafna D Gladman. (2018) Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial. The Lancet 392:10162, pages 2367-2377.
Crossref
Crossref
Rubén Queiro, Anahy Brandy, Mª Carmen Rosado, Andrés Lorenzo, Pablo Coto, Carmen Carriles, Mercedes Alperi & Javier Ballina. (2018) Minimal Disease Activity and Patient-Acceptable Symptom State in Psoriatic Arthritis. JCR: Journal of Clinical Rheumatology 24:7, pages 381-384.
Crossref
Crossref
Jessica A. WalshOluwakayode AdejoroBenjamin ChastekJacqueline B. PalmerPeter Hur. (2018) Treatment Patterns Among Patients with Psoriatic Arthritis Treated with a Biologic in the United States: Descriptive Analyses from an Administrative Claims Database. Journal of Managed Care & Specialty Pharmacy 24:7, pages 623-631.
Crossref
Crossref
Tomas Mlcoch, Jan Tuzil, Liliana Sedova, Jiri Stolfa, Monika Urbanova, David Suchy, Andrea Smrzova, Jitka Jircikova, Tereza Hrnciarova, Karel Pavelka & Tomas Dolezal. (2017) Mapping Quality of Life (EQ-5D) from DAPsA, Clinical DAPsA and HAQ in Psoriatic Arthritis. The Patient - Patient-Centered Outcomes Research 11:3, pages 329-340.
Crossref
Crossref
Lucia Sara D’Angiolella, Paolo Angelo Cortesi, Alessandra Lafranconi, Mariangela Micale, Sveva Mangano, Giancarlo Cesana & Lorenzo Giovanni Mantovani. (2018) Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: A Systematic Literature Review. PharmacoEconomics 36:5, pages 567-589.
Crossref
Crossref
Jessica A. WalshOluwakayode AdejoroBenjamin ChastekJacqueline B. PalmerPeter Hur. (2018) Treatment Patterns Among Patients with Psoriatic Arthritis Treated with a Biologic in the United States: Descriptive Analyses from an Administrative Claims Database. Journal of Managed Care & Specialty Pharmacy, pages 1-11.
Crossref
Crossref